PORTLAND, Ore.--(BUSINESS WIRE)--Bioject Medical Technologies Inc. (OTCBB:BJCT), a leading developer of needle-free injection therapy systems, today announced that it has met a significant milestone under its Development Agreement with Merial Limited (“Merial”) by delivering to Merial working prototype devices and auto-disable syringes for its next generation spring-powered companion animal device. This new device will allow veterinarians to deliver multiple Merial companion animal vaccines using a single device.
